Skip to Main Content

Paper Details

Evolving Treatment Patterns and Outcomes of Neovascular Age-Related Macular Degeneration Over a Decade.
Ophthalmol Retina
6
2021
Neovascular Age-Related Macular Degeneration, PARTICIPANTS, Patients, VEGF, anti-vascular endothelial growth factor, nAMD, neovascular age-related macular degeneration, patients
Angiogenesis Inhibitors, Electronic Health Records, Female, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Intravitreal Injections, Macula Lutea, Male, Middle Aged, Ranibizumab, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Retrospective Studies, Time Factors, Treatment Outcome, Vascular Endothelial Growth Factor A, Visual Acuity, Wet Macular Degeneration
Author NameAffiliation
Roy SchwartzMoorfields Eye Hospital NHS Foundation Trust, United Kingdom Institute of Health Informatics, University College London
Alasdair WarwickMoorfields Eye Hospital NHS Foundation Trust, United Kingdom Institute of Cardiovascular Science, University College London
Abraham Olvera-BarriosMoorfields Eye Hospital NHS Foundation Trust, United Kingdom Institute of Ophthalmology, University College London
Maria PikoulaInstitute of Health Informatics, University College London
Aaron LeeUniversity of Washington
Spiros DenaxasInstitute of Health Informatics, University College London, United Kingdom The Alan Turing Institute, United Kingdom The National Institute for Health Research University College London Hospitals Biomedical Research Centre, United Kingdom British Heart Foundation Research Accelerator
Paul TaylorInstitute of Health Informatics, University College London
Catherine EganMoorfields Eye Hospital NHS Foundation Trust, United Kingdom Institute of Ophthalmology, University College London
Usha ChakravarthyCenter for Public Health, The Queen's University of Belfast
Peck Lin Lip
Adnan TufailMoorfields Eye Hospital NHS Foundation Trust, United Kingdom Institute of Ophthalmology, University College London
  • 1 - 11

Datasets

Release 1.2